Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines

Cancer Chemotherapy and Pharmacology

Volumn 43, Issue 4, 1999, Pages 341-347

  Lokshin, Anna ^a,b   Peng, Xiaojun ^a   Campbell, Phil G ^a   Barsouk, Alexander ^a   Levitt, Mark L ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Agarose immobilization; Growth factor receptors; Growth stimulation; Non small cell lung cancer; Suramin

Indexed keywords

AGAROSE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; POLYSULFONE; PURINE RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SOMATOMEDIN B; SURAMIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; DIMERIZATION; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; DIMERIZATION; DNA, NEOPLASM; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LUNG NEOPLASMS; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURAMIN; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0033020115     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050905     Document Type: Article

References (34)

1. 1. Baghdiguian S, Boudier JA, Boudier JL, Fantini J (1993) Autoradiographic localization of tritiated suramin in polarized human colon adenocarcinoma cells. Cancer Lett 75: 151
2. 2. Berns EM, Schuurmans AL, Bolt J, Lamb DJ, Foekens JA, Mulder E (1990) Antiproliferative effects of suramin on androgen responsive tumour cells. Eur J Cancer 26: 470
3. 3. Bojanowski K, Lelievre S, Markovits J, Couprie J, Jacquemin-Sablon A, Larsen AK (1992) Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells. Proc Natl Acad Sci USA 89: 3025
4. 4. Campbell PG, Novak JF, Yanosick TB, McMaster JH (1992) Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex. Endocrinology 130: 1401
5. 5. Cardinali M, Sartor O, Robbins KC (1992) Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells. J Clin Invest 89: 1242
6. 6. Castro E, Mateo J, Tome AR, Barbosa RM, Miras-Portugal MT, Rosario LM (1995) Cell-specific purinergic receptors coupled to Ca2 + entry and Ca2 + release from internal stores in adrenal chromaffin cells. Differential sensitivity to UTP and suramin. J Biol Chem 270: 5098
7. 7. Estival A, Monzat V, Miquel K, Gaubert F, Hollande E, Korc M, Vaysse N, Clemente F (1996) Differential regulation of fibroblast growth factor (FGF) receptor-1 mRNA and protein by two molecular forms of basic FGF. Modulation of FGFR-1 mRNA stability. J Biol Chem 271: 5663
8. 8. Ewing MW, Liu SC, Gnarra JR, Walther MM, Meyers CE, Linehan WM (1993) Effect of suramin on the mitogenic response of the human prostate carcinoma cell line PC-3. Cancer 71: 1151
9. 9. Fantini J, Rognoni JB, Roccabianca M, Pommier G, Marvaldi J (1989) Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4. J Biol Chem 264: 10282
10. 10. Favoni RE, Ravera F, Pirani P, Ardizzoni A, Noonan D, de Cupis A (1994) Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines. Eur J Pharmacol 264: 199
11. 11. Firsching A, Nickel P, Mora P, Allolio B (1995) Antiproliferative and angiostatic activity of suramin analogues. Cancer Res 55: 4957
12. 12. Fleming TP, Matsui T, Aaronson SA (1992) Platelet-derived growth factor (PDGF) receptor activation in cell transformation and human malignancy. Exp Gerontol 27: 523
13. 13. Foekens JA, Sieuwerts AM, Stuurman-Smeets EM, Dorssers LC, Berns EM, Klijn JG (1992) Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro. Int J Cancer 51: 439
14. 14. Fujiuchi S, Ohsaki Y, Kikuchi K (1997) Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor. Oncology 54: 134
15. 15. Funayama Y, Nishio K, Takeda Y, Kubota N, Ohira T, Ohmori T, Ohta S, Ogasawara H, Hasegawa S, Saijo N (1993) Suramin inhibits the phosphorylation and catalytic activity of DNA topoisomerase II in human lung cancer cells. Anticancer Res 13: 1981
16. 16. Gansler T, Vaghmar N, Olson JJ, Graham SD (1992) Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures. J Urol 148: 910
17. 17. Gill JS, Connolly DC, McManus MJ, Maihle NJ, Windebank AJ (1996) Suramin induces phosphorylation of the high-affinity nerve growth factor receptor in PC12 cells and dorsal root ganglion neurons. J Neurochem 66: 963
18. 18. Hensey CE, Boscoboinik D, Azzi A (1989) Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2 A. FEBS Lett 258: 156
19. 19. Horne MK 3rd, Stein CA, LaRocca RV, Myers CE (1988) Circulating glycosaminoglycan anticoagulants associated with suramin treatment. Blood 71: 273
20. 20. Jindal HK, Anderson CW, Davis RG, Vishwanatha JK (1990) Suramin affects DNA synthesis in HeLa cells by inhibition of DNA polymerases. Cancer Res 50: 7754
21. 21. Kopp R, Pfeiffer A (1990) Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells. Cancer Res 50: 6490
22. 22. Lokshin A, Levitt ML (1996) Effect of suramin on squamous differentiation and apoptosis in three human non-small-cell lung cancer cell lines. J Cell Biochem Suppl 24: 186
23. 23. Middaugh CR, Mach H, Burke CJ, Volkin DB, Dabora JM, Tsai PK, Bruner MW, Ryan JA, Marfia KE (1992) Nature of the interaction of growth factors with suramin. Biochemistry 31: 9016
24. 24. Mirza MR, Jakobsen E, Pfeiffer P, Lindebjerg-Clasen B, Bergh J, Rose C (1997) Suramin in non-small cell lung cancer and advanced breast cancer. Two parallel phase II studies. Acta Oncol 36: 171
25. 25. Morocz IA, Lauber B, Schmitter D, Stahel RA (1993) In vitro effect of suramin on lung tumour cells. Eur J Cancer 29 A: 245
26. 26. Olivier S, Formento P, Fischel JL, Etienne MC, Milano G (1990) Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. Eur J Cancer 26: 867
27. 27. Pommier GJ, Garrouste FL, el Atiq F, Roccabianca M, Marvaldi JL, Remacle-Bonnet MM (1992) Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonie adenocarcinoma cell line. Cancer Res 52: 3182
28. 28. Rubio GJ, Pinedo HM, Virizuela J, van Ark-Otte J, Giaccone G (1995) Effects of suramin on human lung cancer cell lines. Eur J Cancer 31 A: 244
29. 29. Schrell UM, Gauer S, Kiesewetter F, Bickel A, Hren J, Adams EF, Fahlbusch R (1995) Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop. J Neurosurg 82: 600
30. 30. Shin R, Naomoto Y, Kamikawa Y, Tanaka N, Orita K (1997) Effect of suramin on human esophageal cancer cells in vitro and in vivo. Scand J Gastroenterol 32: 824
31. 31. Stein CA (1993) Suramin: a novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res 53: 2239
32. 32. Stein CA, LaRocca RV, Thomas R, McAtee N, Myers CE (1989) Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncol 7: 499
33. 33. Waltz TM, Abdiu A, Wingren S, Smeds S, Larsson SE, Wasteson A (1991) Suramin inhibits growth of human osteosarcoma xenografts in nude mice. Cancer Res 51: 3585
34. 34. Zielke A, Wong MG, Siperstein AE, Clark OH, Rothmund M, Duh QY (1997) Antiproliferative effect of suramin on primary cultures of human pheochromocytomas and rat PC 12 pheochromocytoma cells. J Surg Oncol 66: 11